175 related articles for article (PubMed ID: 36142828)
1. A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9.
Li L; Yang M; Yu J; Cheng S; Ahmad M; Wu C; Wan X; Xu B; Ben-David Y; Luo H
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142828
[TBL] [Abstract][Full Text] [Related]
2. A novel L-phenylalanine dipeptide inhibits prostate cancer cell proliferation by targeting TNFSF9.
Zhang D; Liu B; Hu L; Yu J; Cheng S; Ahmad M; Xu BX; Luo H
Biomed Pharmacother; 2023 Apr; 160():114360. PubMed ID: 36804121
[TBL] [Abstract][Full Text] [Related]
3. Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism.
Gil-Araujo B; Toledo Lobo MV; Gutiérrez-Salmerón M; Gutiérrez-Pitalúa J; Ropero S; Angulo JC; Chiloeches A; Lasa M
Mol Oncol; 2014 Feb; 8(1):27-38. PubMed ID: 24080497
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-tumor activity evaluation of Matijin-Su derivatives.
Xu B; Wang N; Pan W; Qiu J; Cao P; Zhu M; Feng Y; Liang G
Bioorg Chem; 2014 Oct; 56():34-40. PubMed ID: 24930072
[TBL] [Abstract][Full Text] [Related]
6. DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer.
Shen J; Zhou S; Shi L; Liu X; Lin H; Yu H; Xiaoliang ; Tang J; Yu T; Cai X
Oncotarget; 2017 Feb; 8(7):12133-12144. PubMed ID: 28129656
[TBL] [Abstract][Full Text] [Related]
7. TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma.
Shen YL; Gan Y; Gao HF; Fan YC; Wang Q; Yuan H; Song YF; Wang JD; Tu H
J Dig Dis; 2017 Jul; 18(7):395-403. PubMed ID: 28547807
[TBL] [Abstract][Full Text] [Related]
8. TNFSF9 promotes metastasis of pancreatic cancer through Wnt/Snail signaling and M2 polarization of macrophages.
Wu J; Wang Y; Yang Y; Liu F; Chen J; Jiang Z; Jiang Z
Aging (Albany NY); 2021 Sep; 13(17):21571-21586. PubMed ID: 34517345
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol promotes apoptosis through the induction of dual specificity phosphatase 1 and sensitizes prostate cancer cells to cisplatin.
Martínez-Martínez D; Soto A; Gil-Araujo B; Gallego B; Chiloeches A; Lasa M
Food Chem Toxicol; 2019 Feb; 124():273-279. PubMed ID: 30552915
[TBL] [Abstract][Full Text] [Related]
10.
Yao Q; Wang Y; Dong Z; Lai C; Chang B; Gong Q; Ren S; Sun D; Lu J; Gao Y
Front Pharmacol; 2020; 11():608199. PubMed ID: 33643039
[No Abstract] [Full Text] [Related]
11. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
12. A Novel Tanshinone Analog Exerts Anti-Cancer Effects in Prostate Cancer by Inducing Cell Apoptosis, Arresting Cell Cycle at G2 Phase and Blocking Metastatic Ability.
Wang M; Zeng X; Li S; Sun Z; Yu J; Chen C; Shen X; Pan W; Luo H
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510010
[TBL] [Abstract][Full Text] [Related]
13. CDKN2B antisense RNA 1 suppresses tumor growth in human colorectal cancer by targeting MAPK inactivator dual-specificity phosphatase 1.
Pan J; Lin M; Xu Z; Xu M; Zhang J; Weng Z; Lin B; Lin X
Carcinogenesis; 2021 Nov; 42(11):1399-1409. PubMed ID: 34436551
[TBL] [Abstract][Full Text] [Related]
14. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.
Baniwal SK; Khalid O; Gabet Y; Shah RR; Purcell DJ; Mav D; Kohn-Gabet AE; Shi Y; Coetzee GA; Frenkel B
Mol Cancer; 2010 Sep; 9():258. PubMed ID: 20863401
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer.
Guo F; Zhang C; Wang F; Zhang W; Shi X; Zhu Y; Fang Z; Yang B; Sun Y
Cell Death Differ; 2020 Jun; 27(6):1938-1951. PubMed ID: 31857702
[TBL] [Abstract][Full Text] [Related]
16. Fli-1 Activation through Targeted Promoter Activity Regulation Using a Novel 3', 5'-diprenylated Chalcone Inhibits Growth and Metastasis of Prostate Cancer Cells.
Ma Y; Xu B; Yu J; Huang L; Zeng X; Shen X; Ren C; Ben-David Y; Luo H
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210104
[TBL] [Abstract][Full Text] [Related]
17. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
Lu Z; Zhou R; Kong Y; Wang J; Xia W; Guo J; Liu J; Sun H; Liu K; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
[TBL] [Abstract][Full Text] [Related]
18. KZL204, a Trifluoromethylated Quinazoline Derivative, Exhibits High Potent Anti-Tumor Effects on Glioblastoma Multiforme U251MG Cells.
Huang Y; Yu J; Cheng S; Luo H; Hu X
Ann Clin Lab Sci; 2023 Nov; 53(6):861-871. PubMed ID: 38182147
[TBL] [Abstract][Full Text] [Related]
19. Targeting epithelial to mesenchymal transition in prostate cancer by a novel compound, plectranthoic acid, isolated from Ficus microcarpa.
Akhtar N; Syed DN; Lall RK; Mirza B; Mukhtar H
Mol Carcinog; 2018 May; 57(5):653-663. PubMed ID: 29436741
[TBL] [Abstract][Full Text] [Related]
20. Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis.
Méndez-Clemente A; Bravo-Cuellar A; González-Ochoa S; Santiago-Mercado M; Palafox-Mariscal L; Jave-Suárez L; Solorzano-Ibarra F; Villaseñor-García M; Ortiz-Lazareno P; Hernández-Flores G
Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]